BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 11485396)

  • 1. Influence of the small leader exons 2 and 3 on human immunodeficiency virus type 1 gene expression.
    Krummheuer J; Lenz C; Kammler S; Scheid A; Schaal H
    Virology; 2001 Aug; 286(2):276-89. PubMed ID: 11485396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The strength of the HIV-1 3' splice sites affects Rev function.
    Kammler S; Otte M; Hauber I; Kjems J; Hauber J; Schaal H
    Retrovirology; 2006 Dec; 3():89. PubMed ID: 17144911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of HIV-1 envelope protein synthesis by Tat and Rev in 293 cells.
    Natarajan V; Radjendirane V; Salzman NP
    Virology; 1993 Sep; 196(1):122-9. PubMed ID: 8356789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effects of intronic and exonic locations of the human immunodeficiency virus type 1 Rev-responsive element.
    Campbell LH; Borg KT; Arrigo SJ
    Virology; 1996 May; 219(2):423-31. PubMed ID: 8638408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exon 1 leader sequences downstream of U5 are important for efficient human immunodeficiency virus type 1 gene expression.
    Lenz C; Scheid A; Schaal H
    J Virol; 1997 Apr; 71(4):2757-64. PubMed ID: 9060629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Limitation of Tat-associated transcriptional processivity in HIV-infected PBMC.
    Adams M; Wong C; Wang D; Romeo J
    Virology; 1999 May; 257(2):397-405. PubMed ID: 10329550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multigene lentiviral vectors based on differential splicing and translational control.
    Zhu Y; Feuer G; Day SL; Wrzesinski S; Planelles V
    Mol Ther; 2001 Oct; 4(4):375-82. PubMed ID: 11592842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutation of the major 5' splice site renders a CMV-driven HIV-1 proviral clone Tat-dependent: connections between transcription and splicing.
    Bohne J; Kräusslich HG
    FEBS Lett; 2004 Apr; 563(1-3):113-8. PubMed ID: 15063733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular approaches to inhibit HIV-1 tat expression and functions.
    Grossi MP; Caputo A; Zucchini S; Bozzini R; Marconi PC; Manservigi R; Barbanti-Brodano G; Balboni PG
    Year Immunol; 1993; 7():199-204. PubMed ID: 8396820
    [No Abstract]   [Full Text] [Related]  

  • 10. RNA recognition and regulation of HIV-1 gene expression by viral factor Tat.
    Naryshkin NA; Gait MJ; Ivanovskaya MG
    Biochemistry (Mosc); 1998 May; 63(5):489-503. PubMed ID: 9632883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Second exon of Tat of HIV-2 is required for optimal trans-activation of HIV-1 and HIV-2 LTRs.
    Tong-Starksen SE; Baur A; Lu XB; Peck E; Peterlin BM
    Virology; 1993 Aug; 195(2):826-30. PubMed ID: 8337847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controlling human immunodeficiency virus type 1 gene expression by unnatural peptides.
    Huq I; Ping YH; Tamilarasu N; Rana TM
    Biochemistry; 1999 Apr; 38(16):5172-7. PubMed ID: 10213623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mathematical model of the Tat-Rev regulation of HIV-1 replication in an activated cell predicts the existence of oscillatory dynamics in the synthesis of viral components.
    Likhoshvai VA; Khlebodarova TM; Bazhan SI; Gainova IA; Chereshnev VA; Bocharov GA
    BMC Genomics; 2014; 15 Suppl 12(Suppl 12):S1. PubMed ID: 25564443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of HIV-1 replication by novel lentiviral vectors expressing transdominant Rev and HIV-1 env antisense.
    Mautino MR; Morgan RA
    Gene Ther; 2002 Apr; 9(7):421-31. PubMed ID: 11938457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In silico mutagenesis of RNA splicing in HIV-1.
    Kim H; Yin J
    Biotechnol Bioeng; 2005 Sep; 91(7):877-93. PubMed ID: 15937951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple modes of transcriptional regulation by the HIV-1 Tat transactivator.
    Marcello A; Zoppé M; Giacca M
    IUBMB Life; 2001 Mar; 51(3):175-81. PubMed ID: 11547919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human immunodeficiency virus-1 tat- and tat/nef-defective genomes containing HIV-regulated diphtheria toxin A chain gene inhibit HIV replication.
    Brdar B; Matulić M; Rubelj I; Ivanković M; Reich E
    Croat Med J; 2002 Oct; 43(5):591-7. PubMed ID: 12402403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of a spliced exon product of herpes simplex type-1 latency-associated transcript in productively infected cells.
    Kang W; Mukerjee R; Gartner JJ; Hatzigeorgiou AG; Sandri-Goldin RM; Fraser NW
    Virology; 2006 Dec 5-20; 356(1-2):106-14. PubMed ID: 16938324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of nuclease resistant circular RNA decoys for HIV-Tat and HIV-Rev by autocatalytic splicing.
    Puttaraju M; Been MD
    Nucleic Acids Symp Ser; 1995; (33):152-5. PubMed ID: 8643355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chapter 1. Regulation of HIV-1 alternative RNA splicing and its role in virus replication.
    Stoltzfus CM
    Adv Virus Res; 2009; 74():1-40. PubMed ID: 19698894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.